Wednesday
SESSION 44: MORE NEW DEVELOPMENTS RELATING TO AAAs AND EVAR
Moderators:Juan C. Parodi, MD / Daniel G. Clair, MD  
SESSION 44 SCHEDULE
2:00 PM - 2:05 PM An Evolution Related Classification System To Help Select The Optimal AAA Endograft For Each EVAR Patient
  Presenter(s):Claude Mialhe, MD  
  View Slides in PDF      
2:06 PM - 2:11 PM High 18 F-FDG Uptake On PET CT In The Aortic Wall Of AAAs Predicts Poor Results Of Treatment And Poor Patient Survival: Why
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Slides in PDF      
2:12 PM - 2:17 PM Why Diabetes Is Negatively Associated With AAA Incidence And Growth: A Possible Clue To Medical Treatment Of AAAs
  Presenter(s):Jes S. Lindholt, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM Do New Low Profile EVAR Devices Come At The Cost Of Poorer Durability
  Presenter(s):Michel Makaroun, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM Despite The Declining Incidence Of AAAs, Current AAA Screening Programs Have Value And Save Lives: How Should They Be Structured In 2016 And Beyond
  Presenter(s):Martin Bjorck, MD, PhD  
  View Slides in PDF      
2:30 PM - 2:35 PM DEBATE: On Label Use (Within The IFU) Of Endografts For EVAR Is Key To Achieving Good Results
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
2:36 PM - 3:41 PM DEBATE: Not So: Outcomes For EVAR Using Endografts Outside Their IFU Can Be As Good As Those Within The IFU If Certain Conditions Are Met
  Presenter(s):Peter L. Faries, MD, FACS  
  View Slides in PDF      
2:42 PM - 2:47 PM Risk Assessment And Risk Scores Have Little Value In The EVAR Treatment Of AAAs – In Contrast To Open Treatment
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
2:48 PM - 2:53 PM Risk Scoring For Ruptured AAAs Is Of No Value And A Waste Of Time
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
2:54 PM - 2:59 PM Nellix Endografts (EVAS) Are Useful For Relining And Treating Failed Previous AAA Repairs (Open And Endo): Technique And Results: The Dutch Experience
  Presenter(s):Barend M.E. Mees, MD, PhD  
  View Slides in PDF      
3:00 PM - 3:10 PM Panel Discussion (Refreshments Available In Back Of Room)
END OF SESSION 44
previous next